A detailed history of Comerica Bank transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 1,113 shares of AMRX stock, worth $8,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,113
Previous 931 19.55%
Holding current value
$8,737
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.42 - $8.83 $1,168 - $1,607
182 Added 19.55%
1,113 $9,000
Q2 2024

Aug 15, 2024

BUY
$5.36 - $7.11 $144 - $191
27 Added 2.99%
931 $5,000
Q1 2024

May 15, 2024

SELL
$5.24 - $6.34 $1,834 - $2,219
-350 Reduced 27.91%
904 $5,000
Q4 2023

Feb 14, 2024

SELL
$3.36 - $6.21 $252 - $465
-75 Reduced 5.64%
1,254 $7,000
Q3 2023

Nov 21, 2023

BUY
$2.76 - $4.59 $3,668 - $6,100
1,329 New
1,329 $5,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.19B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.